Angiotensin Converting Enzyme 2 News and Research

RSS
The response of four SARS-CoV-2 spike variants to linoleic acid removal

The response of four SARS-CoV-2 spike variants to linoleic acid removal

26 Apr 2022
Quantum dot biomimetic for SARS-CoV-2 examines neurovascular dysregulation related to brain inflammation

Quantum dot biomimetic for SARS-CoV-2 examines neurovascular dysregulation related to brain inflammation

26 Apr 2022
Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

26 Apr 2022
A novel mouse model to test SARS-CoV-2 viral infection

A novel mouse model to test SARS-CoV-2 viral infection

26 Apr 2022
Scientists discover how SARS-CoV-2 activates platelets

Scientists discover how SARS-CoV-2 activates platelets

25 Apr 2022
The challenges of Omicron

The challenges of Omicron

25 Apr 2022
Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

24 Apr 2022
Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

22 Apr 2022
Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

22 Apr 2022
Antibody escape in SARS-CoV-2 Omicron spike protein

Antibody escape in SARS-CoV-2 Omicron spike protein

22 Apr 2022
Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

22 Apr 2022
Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

21 Apr 2022
Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

21 Apr 2022
Evolution of SARS-CoV-2 variants

Evolution of SARS-CoV-2 variants

21 Apr 2022
Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

21 Apr 2022
Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

21 Apr 2022
Investigating the impact of SARS-CoV-2 Omicron spike mutations

Investigating the impact of SARS-CoV-2 Omicron spike mutations

20 Apr 2022
Study investigates co-metabolism during SARS-CoV-2 infection

Study investigates co-metabolism during SARS-CoV-2 infection

20 Apr 2022
Waning antibody responses in SARS-CoV-2-infected children and adults over time

Waning antibody responses in SARS-CoV-2-infected children and adults over time

20 Apr 2022
Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

20 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback